Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions. Issue 8 (11th March 2015) - Dunbar, Nancy M.
Abstract BACKGROUND Many hospital transfusion services prioritize ABO plasma compatibility in platelet (PLT) transfusion to minimize risk for acute hemolytic transfusion reactions. In spite of the low risk of D alloimmunization associated with apheresis PLT transfusion, attempts may also be made to provide D– PLTs to D– patients. This study was undertaken to assess how often ABO compatibility and/or D matching occurs at our institution and how the ABO and D mix of our PLT supply impacts PLT selection. STUDY DESIGN AND METHODS We retrospectively reviewed the ABO and D type of all PLTs transfused plus the age, sex, and ABO and D type of all PLT recipients between January 2010 and March 2014 (51 months). RESULTS We provided ABO‐identical PLTs for 5281 (54.6%), ABO plasma–compatible and cellular‐incompatible for 3136 (32.4%), ABO low‐titer plasma‐incompatible and cellular‐compatible for 1150 (11.9%), ABO plasma–incompatible and cellular‐compatible for 30 (0.3%), and ABO plasma–incompatible and cellular‐incompatible for 72 (0.7%). PLT supply did not match PLT demand based on patient ABO type, primarily due to a lower than expected supply of group O PLTs and higher than expected supply of group A and AB. D– patients were less likely to receive ABO‐identical PLT transfusions (p = 0.0008), but were more likely to receive D– PLT transfusions (p < 0.0001). CONCLUSION At our hospital, available inventory and PLT selection practices resulted in the majority of group O patients receiving cellular‐incompatible PLT transfusions. Efforts to provide D– PLTs to D– patients also resulted in fewer D– patients receiving ABO‐identical PLT transfusions.